Machine Learning to Refine Selection Criteria of PostOperative Radiotherapy for Resectable Stage III-N2 NonSmall Cell Lung Cancer

被引:0
|
作者
Zarinshenas, R. [1 ]
Ladbury, C. J. [1 ]
Mcgee, H. M. [1 ]
Raz, D. [2 ]
Erhunmwunsee, L. [2 ,3 ]
Pathak, R. [4 ]
Glaser, S. M. [1 ]
Salgia, R. [4 ]
Williams, T. M. [1 ]
Amini, A. [1 ]
机构
[1] City Hope Natl Med Ctr, Dept Radiat Oncol, 1500 E Duarte Rd, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Dept Surg, 1500 E Duarte Rd, Duarte, CA 91010 USA
[3] City Hope Natl Med Ctr, Dept Populat Sci, 1500 E Duarte Rd, Duarte, CA 91010 USA
[4] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, 1500 E Duarte Rd, Duarte, CA 91010 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2893
引用
收藏
页码:E400 / E400
页数:1
相关论文
共 50 条
  • [31] A Prospective Randomized Study of Adjuvant Chemotherapy in Completely Resected Stage III-N2 Non Small Cell Lung Cancer
    王思愚
    区伟
    林勇斌
    梁颖
    叶雄
    张彬彬
    杨桦
    ChineseJournalofCancerResearch, 2007, (03) : 189 - 194
  • [32] The additional radiotherapy to adjuvant chemotherapy improves the prognosis of stage III-N2 with highest mediastinal lymph node metastasis in non-small cell lung cancer
    Guo, Jianbo
    Zhang, Lei
    Zhang, Liping
    Wu, Junqi
    Xu, Long
    E, Haoran
    Li, Chongwu
    Wu, Hongyu
    Zhao, Deping
    Hu, Yumin
    Zhang, Jie
    Hu, Xuefei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (14) : 13311 - 13321
  • [33] Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer
    Jeremic, B
    Shibamoto, Y
    Acimovic, L
    Milisavljevic, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (03): : 521 - 525
  • [34] The additional radiotherapy to adjuvant chemotherapy improves the prognosis of stage III-N2 with highest mediastinal lymph node metastasis in non-small cell lung cancer
    Jianbo Guo
    Lei Zhang
    Liping Zhang
    Junqi Wu
    Long Xu
    Haoran E
    Chongwu Li
    Hongyu Wu
    Deping Zhao
    Yumin Hu
    Jie Zhang
    Xuefei Hu
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 13311 - 13321
  • [35] SURGERY FOR STAGE IIIA-N2 NONSMALL CELL LUNG-CANCER
    MOUNTAIN, CF
    CANCER, 1994, 73 (10) : 2589 - 2598
  • [36] Effect of postoperative radiotherapy on outcome in resectable stage IIIA-N2 non-small-cell lung cancer: an updated meta-analysis
    Sakib, Nazmus
    Li, Na
    Zhu, Xiaoxia
    Li, Dianhe
    Li, Yiyi
    Wang, Haofei
    NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (01) : 51 - 59
  • [37] Preoperative concurrent chemoradiotherapy for unresectable stage III nonsmall cell lung cancer
    Milstein, D
    Kuten, A
    Saute, M
    Best, LA
    Daoud, K
    ZenAlDeen, I
    Dale, J
    Robinson, E
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 34 (05): : 1125 - 1132
  • [38] Definitive chemoradiotherapy in Stage III nonsmall cell lung cancer: Turkey experience
    Yilmaz, Ufuk
    Yilmaz, Ulku
    Yasar, Zehra
    Kirakli, Esra Korkmaz
    Ulger, Sukran
    Ozdogan, Yasemin
    Demirci, Nilgun Yilmaz
    Erol, Serhat
    Ozdogan, Ilker
    Sahin, Burcu
    Koksal, Deniz
    Akcay, Cimen
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (01) : 334 - 339
  • [39] Stage III nonsmall cell lung cancer: Still a challenge for the radiation oncologist
    VanHoutte, P
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (03): : 533 - 535
  • [40] Selection of proper candidates with resected pathological stage IIIA-N2 non-small cell lung cancer for postoperative radiotherapy
    Hui, Zhouguang
    Dai, Honghai
    Liang, Jun
    Lv, Jima
    Zhou, Zongmei
    Feng, Qinfu
    Xiao, Zefen
    Chen, Dongfu
    Zhang, Hongxing
    Yin, Weibo
    Wang, Luhua
    THORACIC CANCER, 2015, 6 (03) : 346 - 353